Skip to main content
. 2014 Nov 20;112(2):313–318. doi: 10.1038/bjc.2014.561

Figure 3.

Figure 3

(A) Progression-free survival with oxaliplatin based on TL. The clinical outcome to oxaliplatin was determined in relation to TL. Similar to preclinical data, there was no association of TL with oxaliplatin. (B) Progression-free survival with irinotecan based on TL. When the data for irinotecan were considered, there was no association between TL and irinotecan.